1. Safety, Tolerability and efficacy of Rapid Optimization, helped by NT‐proBNP and GDF‐15, of Heart Failure therapies (STRONG‐HF): rationale and design for a multicentre, randomized, parallel‐group study

    http://dx.doi.org/10.1002/ejhf.1575
  2. Author index

    http://dx.doi.org/10.1002/ejhf.1489
  3. Heart Failure 2019 Abstract Reviewers

    http://dx.doi.org/10.1002/ejhf.1529
  4. Issue Information

    http://dx.doi.org/10.1002/ejhf.1487
  5. Abstracts Programme

    http://dx.doi.org/10.1002/ejhf.1488
  6. Haemoconcentration during treatment of acute heart failure with cardiorenal syndrome: from the CARRESS‐HF trial

    http://dx.doi.org/10.1002/ejhf.1592
  7. We told you so: ‘knowledge is not enough to improve heart failure self‐care behaviour’

    http://dx.doi.org/10.1002/ejhf.1580
  8. Down the road from challenges in acute heart failure trials

    http://dx.doi.org/10.1002/ejhf.1571
  9. Validation of the HFA‐PEFF‐score for the Diagnosis of Heart Failure with Preserved Ejection Fraction

    http://dx.doi.org/10.1002/ejhf.1614
  10. Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial

    http://dx.doi.org/10.1002/ejhf.1600
Copyright © 2015 1388-9842的搜索结果由GYCC学术搜索提供 - 意见反馈 >>小额捐赠|打赏